Bailey v. Khoury

891 So. 2d 1268, 2005 WL 115514
CourtSupreme Court of Louisiana
DecidedJanuary 20, 2005
Docket2004-CC-0620, 2004-CC-0647, 2004-CC-0684
StatusPublished
Cited by108 cases

This text of 891 So. 2d 1268 (Bailey v. Khoury) is published on Counsel Stack Legal Research, covering Supreme Court of Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bailey v. Khoury, 891 So. 2d 1268, 2005 WL 115514 (La. 2005).

Opinion

891 So.2d 1268 (2005)

Ginger BAILEY, et al.
v.
Dr. Gregory KHOURY, et al.

Nos. 2004-CC-0620, 2004-CC-0647, 2004-CC-0684.

Supreme Court of Louisiana.

January 20, 2005.

*1270 Adams and Reese, Edward J. Rice, Jr., Arthur F. Hickham, Jr., New Orleans, Counsel for Applicant in No. 2004-CC-0620.

Mang, Batiza, Godofsky & Penzato, Deborah I. Schroeder, Nakisha Ervin-Knott, The Truitt Law Firm, Jack E. Truitt, Madisonville, Broussard and Associates, Kevin K. Gipson, Martin L. Broussard, Jr., New Orleans, Hemelt & Foshee, Deborah C. Foshee, Covington, Seale, Daigle & Ross, Mark E. Seamster, Covington, Counsel for Respondent in No. 2004-CC-0620.

Mang, Batiza, Godofsky & Penzato, Deborah I. Schroeder, Nakisha Ervin-Knott, Counsel for Applicant in No. 2004-CC-0647.

Adams and Reese, Edward J. Rice, Jr., Arthur F. Hickham, Jr., New Orleans, The Truitt Law Firm, Jack E. Truitt, Madisonville, Broussard and Associates, Kevin K. Gipson, Martin L. Broussard, Jr., New Orleans, Hemelt & Foshee, Deborah C. Foshee, Covington, Seale, Daigle & Ross, Mark E. Seamster, Covington, Counsel for Respondent in No. 2004-CC-0647.

The Truitt Law Firm, Jack E. Truitt, Madisonville, Counsel for Applicant in No. 2004-CC-0684.

Adams and Reese, Edward J. Rice, Jr., Arthur F. Hickham, Jr., New Orleans, Mang, Batiza, Godofsky & Penzato, Deborah I. Schroeder, Nakisha Ervin-Knott, Broussard and Associates, Kevin K. Gipson, Martin L. Broussard, Jr., New Orleans, Hemelt & Foshee, Deborah C. Foshee, Covington, Seale, Daigle & Ross, Mark E. Seamster, Covington, Counsel for Respondent in No. 2004-CC-0684.

CALOGERO, Chief Justice.

Rapid advances in many scientific disciplines have led to the application of new methods and technologies in every aspect of medicine. Often these new capabilities require fundamental changes in legal analysis or raise legal questions that never before have required consideration.[1]

This case aptly demonstrates the truth of the above statement, as the primary issue involves the impact on the parties' rights, of information gained from advances in medical technology that raises a legal question "that never before [has] required consideration." In fact, our research indicates that the issue presented may be one of first impression, not only in the State of Louisiana, but in every legal jurisdiction in the United States. The court in this case is called upon to decide whether the time limitation for filing a claim seeking recovery of damages arising from birth defects can be considered to commence at a time prior to the child's live birth when, because of information gained *1271 from an ultrasound of the fetus, the unborn child's parent was told both that the child had birth defects and that those defects were probably caused by the mother's ingestion of drugs prescribed and dispensed by defendants. This argument is only the most recent of many creative legal arguments flowing from rapidly-changing medical and scientific advances which, over the last century, have transformed the legal principles applicable to liability for birth defects and prenatal injuries.[2]

The plaintiff in this case is the mother of a child who suffered birth defects, allegedly as a result of her ingestion of the prescription drug Depakote during the early days of her pregnancy. The mother filed suit in medical malpractice against various health-care providers who prescribed the drug, and in tort against various pharmacies that dispensed the drug, both in her individual capacity and in her representative capacity on behalf of the child. We granted these consolidated applications for supervisory writs to determine whether prescription on both of the plaintiff's claims commenced, as the defendants claim, on the date prior to the child's birth when the mother was told that the child would have defects at birth, probably resulting from her ingestion of Depakote during pregnancy, or, as the plaintiff claims, on the later date when the child was born, or whether different prescriptive periods might apply to the plaintiff's two claims. A divided panel of the court of appeal held that prescription commenced on the mother's claim on behalf of the child, and on the mother's individual claim, on the date of the child's birth. Accordingly, the court of appeal affirmed trial court judgments denying exceptions of prescription filed by the defendants. The court of appeal did not differentiate between the two claims in its decision.

For the reasons explained below, we agree with the court of appeal's holding that prescription on both the mother's claim on behalf of the child and the mother's individual claim commenced on the later of the two dates — i.e., the date when the child was born. Because the mother's original petition regarding the two claims was filed less than a year from the date of the child's birth, we affirm the court of appeal judgment denying defendants' peremptory exceptions of prescription.

FACTS AND PROCEDURAL HISTORY

Plaintiff, Ginger Bailey, a psychiatric patient with a long history of treatment and hospitalization for bipolar disorder, had been treated with various prescription medications over the years. From the date of her diagnosis sometime around 1991 until 1997, Ms. Bailey was treated by various physicians and mental health facilities throughout the greater New Orleans area. During that entire period, during *1272 which Ms. Bailey had two children, she was taking various types of drugs to treat her symptoms, which included hallucinations, paranoia and depression. Neither of her two eldest children suffered any adverse effects arising from her ingestion of the various medications.

In March 1997, Dr. Robert Ancira at Transitional Hospital Corp. of New Orleans ("THC") prescribed Depakote, which is "one of the most widely prescribed anti-seizure drugs," primarily used to treat epilepsy, but also used to treat bipolar disorder.[3] When Dr. Gregory Khoury at Jo Ellen Smith Psychiatric Center later became Ms. Bailey's treating physician, he continued to prescribe Depakote. Ms. Bailey purchased her prescription drug, Depakote, from Walgreen's Louisiana Co., Inc. and Eckerd Corporation. Depakote "has been linked to birth defects and lower IQs among children exposed to it in the womb," with the most common birth defect being spina bifida.[4] Despite the fact that she was of child-bearing age, Ms. Bailey claims that none of the defendant physicians or pharmacies warned her of the dangers of birth defects arising from the use of Depakote during pregnancy. Ms. Bailey further claims that she had never been told during her years of treatment that any of the drugs she was taking to treat her symptoms could cause birth defects.

Several months after she first started taking Depakote, in late July or early August 1997, Ms. Bailey learned that she was pregnant with her third child. At that time, Ms. Bailey was advised by a nurse at the New Orleans Mental Health Center to discontinue all medications and to contact an obstetrician. The pregnancy was confirmed by an obstetrician, Dr. Wayne Grundmeyer, who advised Ms. Bailey on September 25, 1997, of the risk that her child would suffer birth defects caused by the drugs used during her pregnancy, particularly her use of Depakote. Dr. Grundmeyer's fears were confirmed when an ultrasound[5] performed by Dr. Thomas Albert on October 25, 1997, revealed that Ms. Bailey's unborn child had developed birth defects (specifically, a neural tube defect[6]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashley Carollo v. Tulane University
Louisiana Court of Appeal, 2025
Heidi Rieth and Jason Bush v. Maria Munguia
Louisiana Court of Appeal, 2024
Whalen v. Monsanto Company
E.D. Louisiana, 2023
Cook v. Marshall
E.D. Louisiana, 2022
In Re: Medical Review Panel of Mason Heath (M)
Louisiana Court of Appeal, 2021

Cite This Page — Counsel Stack

Bluebook (online)
891 So. 2d 1268, 2005 WL 115514, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bailey-v-khoury-la-2005.